Substance Dependence Clinical Trial
Official title:
Stress, Distress Intolerance, and Drug Dependence
This study is designed to evaluate the relative efficacy of a novel treatment (CBT-IC) versus a standard individual drug-counseling treatment. The novel treatment emphasizes exposure to emotional cues for drug use as part of a comprehensive, yet brief, treatment strategy. These treatments are delivered to opiate-dependent, often poly-substance dependent, individuals in a comprehensive methadone maintenance program who have failed to respond adequately to current treatments.
This study study is designed to test further the efficacy of Cognitive-Behavior Therapy for Interoceptive Cues (CBT-IC - a treatment with a central focus on enhancing a patient's tolerance to the myriad forms of distress—sadness, boredom, anxiety, withdrawal sensations, etc.—that are linked to the stressful lives of drug-dependent individuals, and breaking the link between these emotional cues and drug-related attempts to avoid emotional distress) for intervening with chronically-stressed and treatment-resistant opiate-dependent outpatients. Features of this study of particular relevance to to RFA DA-04-001 include: (1) a focus on opiate-dependent patients undergoing chronic stress; (2) a model for the way in which chronic stress translates into chronic drug use; (2) a focus on the way in which stress-related symptoms serve as trigger for drug use; (3) a focus on both mediators and moderators of treatment that will inform treatment-matching efforts, including a focus on gender differences and emotional avoidance/distress intolerance; and (4) the examination of treatment outcome in a Stage II treatment trial. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00887367 -
EtOH Interaction Study
|
Phase 1 | |
| Completed |
NCT01036061 -
GSK618334 Repeat Dose Study
|
Phase 1 | |
| Completed |
NCT01189799 -
Motivational Therapy for Substance Users With Depression
|
N/A | |
| Completed |
NCT01381133 -
Adolescent Outpatient and Continuing Care Study
|
Phase 3 | |
| Recruiting |
NCT04430257 -
Pre-exposure Prophylaxis (PrEP) for Health
|
N/A | |
| Completed |
NCT01128140 -
Efficacy Trial of Warrior Check-Up
|
Phase 2 | |
| Completed |
NCT03767907 -
Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Trial
|
N/A | |
| Recruiting |
NCT05833399 -
Correlation of Genetic Variations With Clinical Response in Substance Use Disorder
|
||
| Withdrawn |
NCT01515917 -
Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)
|
N/A | |
| Completed |
NCT00208143 -
Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia
|
Phase 4 | |
| Withdrawn |
NCT03762798 -
Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone
|
N/A | |
| Completed |
NCT03048552 -
Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3
|
N/A | |
| Active, not recruiting |
NCT04768920 -
Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)
|
N/A | |
| Recruiting |
NCT05410561 -
Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients
|
N/A | |
| Recruiting |
NCT05679284 -
A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs
|
||
| Withdrawn |
NCT00908206 -
Effects of GSK598809 on Brain Activation in Abstinent Alcoholics
|
Phase 1 | |
| Recruiting |
NCT05348317 -
Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders
|
N/A | |
| Recruiting |
NCT01741415 -
Distress Tolerance Treatment for Substance Users
|
Phase 2 | |
| Active, not recruiting |
NCT01621711 -
Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care
|
N/A | |
| Active, not recruiting |
NCT00609089 -
Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction
|
Phase 1/Phase 2 |